GNLX Earnings & Financial Statements
Genelux Corporation
$2.46
+$0.14(+6.03%)
32
Overall
40
Value
30
Tech
28
Quality
Market Cap
$104.97M
Volume
129.66K
52W Range
$2.29 - $8.54
Target Price
$18.83
GNLX earnings and financial statements: Genelux Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
GNLX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $8.0K | $8.0K | $170.0K |
| Operating income | -$33.21M | -$31.70M | -$24.16M |
| EBITDA | -$34.15M | -$31.79M | -$35.71M |
| Net income | -$32.15M | -$29.87M | -$28.30M |
| EPS (diluted) | $-0.86 | $-0.95 | $-1.16 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $19.03M | $34.72M | $27.89M |
| Total liabilities | $7.48M | $8.44M | $8.42M |
| Shareholders’ equity | $11.54M | $26.27M | $19.47M |
| Cash and equivalents | $5.33M | $8.56M | $9.42M |
| Long-term debt | $1.26M | $1.54M | $1.87M |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | -$25.30M | -$21.23M | -$20.27M |
| Capital expenditure | -$1.10M | -$381.0K | -$1.02M |
| Free cash flow | -$26.40M | -$21.61M | -$21.30M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GNLX | $2.46 | +6.0% | 129.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |